Date：28 July (Thursday)
Time: 15:40 – 17:10 (GMT+8)
Customer Success Manager
Utilizing information technology in the healthcare industry has a long history. It began with simple digitization of patient health data to alleviate storage challenges and gradually developed to expedite health information exchange to facilitate multi-disciplinary collaboration. In the past decade, the maturity of biotechnology has been growing rapidly. For example, Next Generation Sequencing (NGS) and, together with the broader adoption of Clinical Decision Support (CDS) solutions, the model of care delivery is transforming from disease-based to personalized, particularly in the oncology specialty.
Cancer is a complex disease. Patients having the same type of cancer may respond differently so mCODE™ has been created and is being supported by ASCO in collaboration with the MITRE Corporation to guarantee the data quality and serve as a guide for the whole care journey, from diagnosis, treatment planning to survivorship evaluation for oncology patients. Clinical data collected throughout the patient journey does not only support evidence-based oncology care but also lay the foundations for further analysis. In addition, these Real World Data (RWD) databases offer strong repository for the development of diagnostics technologies and therapeutic treatment, service evaluation, quality improvement and advancement of healthcare technology. By analyzing the characteristics of these populations, government and policy makers will be able to formulate strategic and forward-looking goals to address national-wide needs and concerns.